Skip to main content
. 2022 Feb 17;9:834725. doi: 10.3389/fmed.2022.834725

Figure 5.

Figure 5

(A) Enriched gene sets in the HALLMARK collection in samples with high CCL5 expression. (B) Enriched gene sets in REACTOME Pathways databases in samples with high CCL5 expression. (C) Enriched gene sets in Canonical Pathways gene sets in samples with high CCL5 expression. (D) Enriched gene sets in C7 immune gene sets in samples with high CCL5 expression.